Related Experiment Videos
The importance of hemodynamic considerations in essential hypertension
1Division of Hypertension, University of Michigan Medical Center, Ann Arbor 48109-0356.
Insights
Antihypertensive therapy effectively reduces stroke and heart failure risks but shows variable benefits for ischemic heart disease. Complex hemodynamic factors beyond blood pressure influence coronary heart disease outcomes.
Area of Science:
- Cardiology
- Hypertension Research
- Vascular Biology
Background:
- Hypertension is a primary risk factor for cardiovascular morbidity and mortality.
- Antihypertensive therapy reduces stroke and heart failure complications but has variable effects on ischemic heart disease (IHD) mortality.
- The complex relationship between hypertension and IHD suggests factors beyond elevated blood pressure are involved.
Purpose of the Study:
- To explore hemodynamic hypotheses explaining the variable efficacy of antihypertensive therapy in reducing IHD mortality.
- To examine the multifaceted impact of hypertension on coronary heart disease, considering factors beyond simple arterial pressure elevation.
- To offer alternative pathophysiological explanations for IHD risk in subgroups like obesity and the limitations of current antihypertensive treatments.
Main Methods:
- Review of existing literature on hypertension, cardiovascular outcomes, and hemodynamic principles.
- Analysis of potential pathophysiological mechanisms linking hypertension to IHD.
- Exploration of factors such as total peripheral resistance, cardiac output, and myocardial power.
Main Results:
- Hypertension's effect on coronary heart disease is more complex than elevated blood pressure alone.
- Factors like high total peripheral resistance, high cardiac output, and increased myocardial power contribute to IHD risk.
- Structural and functional vascular changes associated with hypertension can impair the myocardial oxygen supply-demand balance.
Conclusions:
- The failure of antihypertensive therapy to consistently normalize IHD event rates may stem from complex hemodynamic and structural vascular alterations.
- Obesity represents a high-risk subgroup where these complex factors may be particularly relevant.
- Further research into these adjunctive pathophysiological mechanisms is needed to optimize IHD risk management in hypertensive patients.
Abstract:
Hypertension is a major risk factor for cardiovascular morbidity and mortality. Antihypertensive therapy consistently reduces complications from stroke and congestive heart failure, whereas benefits from the treatment of ischemic heart disease events are variable. Several plausible explanations, including hemodynamic hypotheses, have been put forth to account for the failure of treatment to more favorably influence mortality from ischemic heart disease. The effect of hypertension on coronary heart disease is probably much more complex than a simple elevation of arterial pressure. Some of these complexities include the potential separate risks of high total peripheral resistance, high cardiac output, increased myocardial power that reflects pressure times flow, and several structural and functional vascular changes. These factors may act in concert to unfavorably alter the balance between myocardial oxygen supply and demand. Several of these factors will be highlighted in an attempt to offer alternative or adjunctive pathophysiologic examinations for the high-risk subgroups of obesity and the failure of antihypertensive therapy to normalize the rate of coronary heart disease events.